VENLO, THE NETHERLANDS -- (MARKET WIRE) -- February 26, 2007 -- QIAGEN (NASDAQ: QGEN), the worldwide leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics, today announced that its wholly owned subsidiary, Genaco Biomedical Products, Inc., and Luminex Corporation received the 2006 Technology Innovation and Leadership Award from Frost and Sullivan. This award was announced on February 21 at the annual Excellence in Healthcare Awards in London. This award is bestowed annually to the company or collaboration demonstrating excellence in innovation. Frost and Sullivan recognized that Genaco and Luminex brought together two proprietary technologies to develop a unique solution for multiplex polymerase chain reaction (PCR) assays used in infectious disease testing.
